Jointown(SH:600998) Shang Hai Zheng Quan Bao·2025-12-17 19:15Core Viewpoint - 九州通医药集团股份有限公司's wholly-owned subsidiary, Hubei Jiuzhou Industrial Park Operation Management Co., Ltd., has participated in the restructuring investment of Aoyuan Meigu Technology Co., Ltd., which has received court approval for its restructuring plan [2][3][4]. Group 1: Restructuring Investment Overview - On April 23, 2025, 九州通's subsidiary signed a restructuring investment agreement with Aoyuan Meigu and its temporary administrator, planning to invest CNY 673.2 million to acquire 360 million shares post-restructuring [2][4]. - On September 24, 2025, a supplementary agreement was signed to adjust the restructuring investment plan, increasing the number of shares to be acquired to 435,930,312, with a total investment of CNY 706.2 million [5]. Group 2: Court Approval of Restructuring Plan - On December 16, 2025, the Xiangyang Intermediate People's Court approved Aoyuan Meigu's restructuring plan, allowing the company to proceed with the execution of the plan and terminating the restructuring process [6][8]. - The court's decision confirmed that the restructuring plan met all legal requirements and was approved by the relevant creditor groups [6][7]. Group 3: Impact on Company Operations and Financials - The restructuring investment aligns with the company's long-term strategic development, enhancing its core competitiveness and enabling deeper collaboration with Aoyuan Meigu in the health and beauty sector [7]. - The execution of the restructuring plan will determine the specific implementation of the investment, with no significant short-term impact on the company's operating performance anticipated [8].